When GlaxoSmithKline's Chris Viehbacher (photo) announced his plans to leave the company, everyone wondered where he would head next. Apparently it's the CEO spot at another company--the position he was passed over for at GSK. As of December 1, Viehbacher will replace Gerard Le Fur as CEO of Sanofi-Aventis. Article